Friday, April 25 2025 | Noon - 1:30pm (virtual)
Expanding Access to Psychedelic-Assisted Therapy
CEO and Co-Founder
Enthea
Sherry Rais, CEO and Co-Founder of Enthea, has helped dozens of organizations raise funds, operate according to their mission and values, and implement processes that enhance their overall efficiency. Sherry believes in living and working in alignment with purpose and is currently focused on creating insurance coverage for psychedelic-assisted therapy to alleviate human suffering. Enthea is a licensed, third-party administrator of health plan benefits with a mission to provide as many people as possible safe and affordable access to innovative mental health benefits, starting with ketamine-assisted therapy. Before this, Sherry consulted for over 10 years with the United Nations and World Bank, implementing poverty reduction programs at the national level in over 35 countries. Sherry holds a master’s degree in public policy and administration from the London School of Economics and a bachelor’s degree in psychology and international development from McGill University. She also completed the Certificate in Psychedelic Therapies and Research from California Institute of Integral Studies (CIIS) in 2021. In addition to being Enthea's CEO, she is the Executive Director of the Boston Psychedelic Research Group and a Strategic Advisor for the CIIS.